BALDI, Eleonora
 Distribuzione geografica
Continente #
NA - Nord America 1.813
EU - Europa 529
AS - Asia 412
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.766
Nazione #
US - Stati Uniti d'America 1.807
CN - Cina 195
IT - Italia 187
SG - Singapore 113
UA - Ucraina 94
GB - Regno Unito 68
DE - Germania 65
TR - Turchia 64
FI - Finlandia 32
SE - Svezia 30
BE - Belgio 17
ID - Indonesia 17
HK - Hong Kong 10
FR - Francia 8
CZ - Repubblica Ceca 7
AT - Austria 5
AU - Australia 5
CA - Canada 5
IR - Iran 5
NL - Olanda 4
PE - Perù 4
PL - Polonia 4
VN - Vietnam 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HU - Ungheria 2
IQ - Iraq 2
ES - Italia 1
HN - Honduras 1
IE - Irlanda 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
MK - Macedonia 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2.766
Città #
Woodbridge 236
Fairfield 182
Chandler 161
Ashburn 132
Ann Arbor 131
Houston 128
Jacksonville 110
Singapore 95
Ferrara 75
Santa Clara 74
Wilmington 58
Cambridge 57
Seattle 53
Milan 43
Nanjing 41
Izmir 40
New York 36
Beijing 32
Princeton 32
Boardman 29
Dearborn 29
Shanghai 29
Addison 21
Brussels 17
Los Angeles 17
Jakarta 16
San Diego 15
Nanchang 14
Bremen 12
Shenyang 12
Hong Kong 10
Bologna 9
Jiaxing 9
Norwalk 8
Brno 7
Changsha 7
Jinan 7
Auburn Hills 6
Hebei 6
Tianjin 6
Des Moines 5
Helsinki 5
London 5
Ningbo 5
Redwood City 5
Rome 5
San Mateo 5
Vienna 5
Washington 5
Frankfurt am Main 4
Guangzhou 4
Lima 4
Warsaw 4
Augusta 3
Dong Ket 3
Indiana 3
Kunming 3
Leawood 3
Mountain View 3
Redmond 3
Sant'elena 3
Turin 3
Udine 3
Ardabil 2
Chicago 2
Győr 2
Hangzhou 2
Harringay 2
Lanzhou 2
Munich 2
Naples 2
Orange 2
Ottawa 2
Philadelphia 2
Poggio Renatico 2
Roncoferraro 2
Tappahannock 2
Toronto 2
Amsterdam 1
Ankara 1
Baotou 1
Changchun 1
Cormeilles-en-Parisis 1
Dublin 1
Espoo 1
Exeter 1
Falkenstein 1
Ferrara di Monte Baldo 1
Hanoi 1
Harbin 1
Hefei 1
Hounslow 1
Hull 1
Kilburn 1
Madrid 1
Mezzolombardo 1
Odesa 1
Paris 1
Pescara 1
Quzhou 1
Totale 2.145
Nome #
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 148
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 139
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 133
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 132
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 129
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 123
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 121
Epidemiological health and social study on multiple sclerosis in the Ferrara province 121
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 113
null 104
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 97
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 92
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 90
null 90
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 85
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 83
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 81
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 76
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 74
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 70
null 66
Increased Levels of Endothelin-1 in Cerebrospinal Fluid Are a Marker of Poor Visual Recovery after Optic Neuritis in Multiple Sclerosis Patients 66
null 66
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 64
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 59
MMP-9 isoforms in serum of Multiple Sclerosis patients 49
Smaller optic nerve diameters and reduced flow velocity of ophthalmic artery suggest a history of optic neuritides: Transorbital Ultrasonography and Doppler Ultrasound in multiple sclerosis 48
null 45
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 42
Trans-anal irrigation in patients with multiple sclerosis: Efficacy in treating disease-related bowel dysfunctions and impact on the gut microbiota: A monocentric prospective study 41
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 40
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 36
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 32
Dimethyl Fumarate Treatment Reduces the Amount but Not the Avidity of the Epstein–Barr Virus Capsid-Antigen-Specific Antibody Response in Multiple Sclerosis: A Pilot Study 23
Studying the Interactions of U24 from HHV-6 in Order to Further Elucidate Its Potential Role in MS 22
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 15
Soluble HLA-G molecules are preponderantly released as HLA-G5 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. 9
Totale 2.824
Categoria #
all - tutte 13.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020316 0 0 0 0 27 59 60 56 39 50 16 9
2020/2021298 21 22 11 31 16 33 8 31 14 41 47 23
2021/2022290 8 36 23 5 15 11 14 14 13 25 24 102
2022/2023381 34 44 9 58 56 41 27 37 33 5 22 15
2023/2024312 23 15 9 4 37 50 19 34 17 18 22 64
2024/2025269 24 29 70 49 97 0 0 0 0 0 0 0
Totale 2.824